Sarepta Therapeutics
SRPT
#2380
Rank
โ‚น514.13 B
Marketcap
โ‚น5,299
Share price
-2.99%
Change (1 day)
-50.53%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -โ‚น644.14

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น670.13. In 2022 the company made an earnings per share (EPS) of -โ‚น687.25 a decrease over its 2021 EPS that were of -โ‚น440.76.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น644.14-6.27%
2022-โ‚น687.2555.92%
2021-โ‚น440.76-27.16%
2020-โ‚น605.09-26.96%
2019-โ‚น828.4678.6%
2018-โ‚น463.87603.9%
2017-โ‚น65.90-85.9%
2016-โ‚น467.295.2%
2015-โ‚น444.1953.1%
2014-โ‚น290.13-0%
2013-โ‚น290.13-33.79%
2012-โ‚น438.207214.29%
2011-โ‚น5.99-96.11%
2010-โ‚น154.0515.38%
2009-โ‚น133.51-23.53%
2008-โ‚น174.59-37.04%
2007-โ‚น277.29-0%
2006-โ‚น277.2945.95%
2005-โ‚น190.00-46.38%
2004-โ‚น354.3240.82%
2003-โ‚น251.62-57.02%
2002-โ‚น585.40-2.56%
2001-โ‚น600.81138.78%
2000-โ‚น251.62-20.97%
1999-โ‚น318.38-72.2%
1998-โ‚น1,145519.44%
1997-โ‚น184.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น375.72-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น615.36-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น265.31-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น106.98-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น351.75-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น740.31 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น451.03-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA